Overview

A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia

Status:
Unknown status
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to explore the efficacy and safety of Kanglaite Injection in the treatment of patients with late-stage cancer cachexia.
Phase:
Phase 4
Details
Lead Sponsor:
Zhejiang Kanglaite Pharmaceutical Co.Ltd
Collaborator:
H & J CRO International, Inc.